# The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest

Study · id `cardio:ct-nct07905482` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07905482](<https://clinicaltrials.gov/study/NCT07905482>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07905482

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 3200 participants.

## Technical summary

Registry record NCT07905482. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-05 (actual); primary completion 2029-03-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3200 participants (planned count; ClinicalTrials.gov record NCT07905482, source copy `cardio:ctgov-nct07905482-2026-10-29`, retrieved 2026-10-31)
- Started: 2026-10-05 (actual) (ClinicalTrials.gov record NCT07905482, source copy `cardio:ctgov-nct07905482-2026-10-29`, retrieved 2026-10-31)
- Primary completion: 2029-03-05 (anticipated) (ClinicalTrials.gov record NCT07905482, source copy `cardio:ctgov-nct07905482-2026-10-29`, retrieved 2026-10-31)
- Completion: 2029-09-05 (anticipated) (ClinicalTrials.gov record NCT07905482, source copy `cardio:ctgov-nct07905482-2026-10-29`, retrieved 2026-10-31)
- Countries: Netherlands (ClinicalTrials.gov record NCT07905482, source copy `cardio:ctgov-nct07905482-2026-10-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07905482-2026-10-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest
- Acronym: REVIVE-PEEP
- Condition: Cardiac Arrest, Out-Of-Hospital
- Intervention (Device): Fixed PEEP Valve
- Intervention (Device): Sham Valve
- Lead sponsor: Jeroen van Eijk
- Lead sponsor class: OTHER
- Collaborator: Dutch Heart Foundation
- Collaborator class: OTHER
- Collaborator: Ambu A/S
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as a collaborator: Hartstichting (`cardio:org-hartstichting`)

## Provenance

Content hash: a5b94c9ef778efc182b48d76f3cec96a1d37d5bc0ea8ff67dec484be02906421
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
